Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661853 · ClinicalTrials.gov registry record · NA
Effect of CBT Microinterventions on Mechanisms of Behavior Change Among Adults With AUD
A NA study of Alcohol Use Disorder, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT03661853: Completed NA study of Alcohol Use Disorder, sponsored by University of Massachusetts, Worcester.
NCT03661853 is a NA study of Alcohol Use Disorder that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 83 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03661853, a NA study of Alcohol Use Disorder, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed R21, Effect of CBT Microinterventions on Mechanisms of Behavior Change among Adults with AUD: Using Eye Tracking to Measure Pre-Post Cognitive Control, uses a translational team science approach to isolate and examine the effect of three different Cognitive Behavioral Therapy (CBT) interventions (functional analysis (FA), cognitive restructuring for alcohol related thoughts (CR), and dealing with cravings (DC)) on specific hypothesized mechanisms (cognitive control, stimulus salience, or craving/arousal, respectively).
Primary Outcome
Changes in drinking behavior are measured by tracking eye movement patterns using antisaccade + attentional bias eyetracking tasks. Specifically, outcome mediators include changes in cognitive control (# of errors in antisaccade eye-tracking task), changes in stimulus salience (stimulus dwell time measurements), and changes in craving/arousal (pupil diameter changes in response to stimuli presentation.)
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Restructuring
- BEHAVIORAL Control
- BEHAVIORAL Functional Analysis
- BEHAVIORAL Dealing With Cravings
Study Locations (1)
Massachusetts
- Elizabeth E Epstein - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2018-08-08 |
| Est. Completion | 2019-07-26 |
| Phase | NA |
What the finished NCT03661853 record still lists
NCT03661853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Restructuring is the first listed.
NCT03661853 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03661853 about?
NCT03661853 is a clinical study titled "Effect of CBT Microinterventions on Mechanisms of Behavior Change Among Adults With AUD". This proposed R21, Effect of CBT Microinterventions on Mechanisms of Behavior Change among Adults with AUD: Using Eye Tracking to Measure Pre-Post Cognitive Control, uses a translational team science approach to isolate and examine the effect of three different Cognitive Behavioral Therapy (CBT) int...
What is the current status of trial NCT03661853?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2018-08-08. Estimated completion is 2019-07-26.
What conditions does trial NCT03661853 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT03661853?
The interventions under investigation include: Cognitive Restructuring (BEHAVIORAL), Control (BEHAVIORAL), Functional Analysis (BEHAVIORAL), Dealing With Cravings (BEHAVIORAL).
Who is sponsoring clinical trial NCT03661853?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03661853 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03661853's enrollment target sits among peer trials
83 98th of 184 higher than 87 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI